<root>
	<PMID Version="1">25496125</PMID>
	<Summary>
		1: Lopes-Ramos CM, Habr-Gama A, Quevedo Bde S, Fel√≠cio NM, Bettoni F, Koyama FC, Asprino PF, Galante PA, Gama-Rodrigues J, Camargo AA, Perez RO, Parmigiani RB.Overexpression of miR-21-5p as a predictive marker for complete tumor regression to neoadjuvant chemoradiotherapy in rectal cancer patients. BMC Med Genomics.2014 Dec 11;7:68. doi: 10.1186/s12920-014-0068-7. PubMed PMID: 25496125; PubMedCentral PMCID: PMC4279677.
	</Summary>
	<MeshHeadingList>
	    <MeshHeading>
			<DescriptorName MajorTopicYN="N" UI="D000230">Adenocarcinoma</DescriptorName>
			<QualifierName MajorTopicYN="N" UI="Q000235">genetics</QualifierName>
			<QualifierName MajorTopicYN="N" UI="Q000473">pathology</QualifierName>
			<QualifierName MajorTopicYN="N" UI="Q000628">therapy</QualifierName>
	    </MeshHeading>
	    <MeshHeading>
			<DescriptorName MajorTopicYN="N" UI="D000971">Antineoplastic Combined Chemotherapy Protocols</DescriptorName>
			<QualifierName MajorTopicYN="Y" UI="Q000627">therapeutic use</QualifierName>
	    </MeshHeading>
	    <MeshHeading>
			<DescriptorName MajorTopicYN="Y" UI="D059248">Chemoradiotherapy</DescriptorName>
	    </MeshHeading>
	    <MeshHeading>
			<DescriptorName MajorTopicYN="N" UI="D005260">Female</DescriptorName>
	    </MeshHeading>
	    <MeshHeading>
			<DescriptorName MajorTopicYN="N" UI="D005500">Follow-Up Studies</DescriptorName>
	    </MeshHeading>
	    <MeshHeading>
			<DescriptorName MajorTopicYN="N" UI="D015972">Gene Expression Regulation, Neoplastic</DescriptorName>
	    </MeshHeading>
	    <MeshHeading>
			<DescriptorName MajorTopicYN="N" UI="D059014">High-Throughput Nucleotide Sequencing</DescriptorName>
	    </MeshHeading>
	    <MeshHeading>
			<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
	    </MeshHeading>
	    <MeshHeading>
			<DescriptorName MajorTopicYN="N" UI="D008297">Male</DescriptorName>
	    </MeshHeading>
	    <MeshHeading>
			<DescriptorName MajorTopicYN="N" UI="D036961">Matrix Attachment Region Binding Proteins</DescriptorName>
			<QualifierName MajorTopicYN="N" UI="Q000235">genetics</QualifierName>
			<QualifierName MajorTopicYN="N" UI="Q000378">metabolism</QualifierName>
	    </MeshHeading>
	    <MeshHeading>
			<DescriptorName MajorTopicYN="N" UI="D035683">MicroRNAs</DescriptorName>
			<QualifierName MajorTopicYN="Y" UI="Q000235">genetics</QualifierName>
	    </MeshHeading>
	    <MeshHeading>
			<DescriptorName MajorTopicYN="N" UI="D008875">Middle Aged</DescriptorName>
	    </MeshHeading>
	    <MeshHeading>
			<DescriptorName MajorTopicYN="Y" UI="D020360">Neoadjuvant Therapy</DescriptorName>
	    </MeshHeading>
	    <MeshHeading>
			<DescriptorName MajorTopicYN="N" UI="D009364">Neoplasm Recurrence, Local</DescriptorName>
			<QualifierName MajorTopicYN="N" UI="Q000235">genetics</QualifierName>
			<QualifierName MajorTopicYN="N" UI="Q000473">pathology</QualifierName>
			<QualifierName MajorTopicYN="Y" UI="Q000628">therapy</QualifierName>
	    </MeshHeading>
	    <MeshHeading>
			<DescriptorName MajorTopicYN="N" UI="D009367">Neoplasm Staging</DescriptorName>
	    </MeshHeading>
	    <MeshHeading>
			<DescriptorName MajorTopicYN="N" UI="D011379">Prognosis</DescriptorName>
	    </MeshHeading>
	    <MeshHeading>
			<DescriptorName MajorTopicYN="N" UI="D012004">Rectal Neoplasms</DescriptorName>
			<QualifierName MajorTopicYN="N" UI="Q000235">genetics</QualifierName>
			<QualifierName MajorTopicYN="N" UI="Q000473">pathology</QualifierName>
			<QualifierName MajorTopicYN="Y" UI="Q000628">therapy</QualifierName>
	    </MeshHeading>
	    <MeshHeading>
			<DescriptorName MajorTopicYN="N" UI="D014408">Tumor Markers, Biological</DescriptorName>
			<QualifierName MajorTopicYN="Y" UI="Q000235">genetics</QualifierName>
			<QualifierName MajorTopicYN="N" UI="Q000378">metabolism</QualifierName>
	    </MeshHeading>
	</MeshHeadingList>
</root>
